Luina Bio

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Revenue

$11.5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Luina Bio

Luina Bio is a Brisbane, Australia based drug development and contract manufacturing organization (CMO) serving the pharmaceutical, biotechnology and veterinary industries. Drawing on more than 20 years of contract manufacturing experience, Luina Bio has the scientific expertise, training and experience to ensure a successful outcome to any project. Utilizing its TGA/APVMA licensed facilities operating to international cGMP standards, Luina Bio provides a comprehensive suite of manufacturing services for both biological and small molecule drugs. Luina Bio has extensive experience in manufacturing recombinant proteins, live therapeutics, whole cell vaccines, viral vaccines, purified plant extracts and pro-biotics for pre-clinical, phase 1 to 3 human clinical trials and commercial products for veterinary industry for clients both within Australia and internationally in the United States, Europe and Asia. In 2017 Luina Bio was the winner of the Queensland Government Export Awards for theRead more
Popular SearchesLuina Bio Pty LtdSIC Code 28,283NAICS Code 32,325Show more

Luina Bio Org Chart

PhoneEmail
JA

Junior Bioprocess Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Luina Bio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Luina Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Luina Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Luina Bio.

Luina Bio News & Media

  • AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

    BRISBANE, AUS, Oct 18, 2022 - (ACN Newswire) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive hires to support global growth plans. International biopharma executive Guillaume Herry has been appointed as CEO, while HR executive Joanne Reichardt has been appointed Head of People & Culture. AcuraBio CEO Guillaume Herry AcuraBio brings two decades
  • Dyadic Announces Sub-Licensing Agreement with Luina Bio

    JUPITER, FL / ACCESSWIRE / April 30, 2019 / Dyadic International, Inc. (''Dyadic'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs and other biologic products, at flexible commercial scales, is pleased to announce it has entered into a worldwide sub-licensing agreement with Australian based drug developme
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Luina Bio

What is Luina Bio's official website?
Luina Bio's official website is www.luina-bio.com
What is Luina Bio's Revenue?
Luina Bio's revenue is $11.5 Million
What is Luina Bio's SIC code?
Luina Bio's SIC: 28,283
What is Luina Bio's NAICS code?
Luina Bio's NAICS: 32,325
How many employees does Luina Bio have?
Luina Bio has 11-50 employees
What industry does Luina Bio belong to?
Luina Bio is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What does Luina Bio do?

Luina Bio is a Brisbane, Australia based drug development and contract manufacturing organization (CMO) serving the pharmaceutical, biotechnology and veterinary industries. Drawing on more than 20 years of contract manufacturing experience, Luina Bio has the scientific expertise, training and experience to ensure a successful outcome to any project... . Utilizing its TGA/APVMA licensed facilities operating to international cGMP standards, Luina Bio provides a comprehensive suite of manufacturing services for both biological and small molecule drugs. Luina Bio has extensive experience in manufacturing recombinant proteins, live therapeutics, whole cell vaccines, viral vaccines, purified plant extracts and pro-biotics for pre-clinical, phase 1 to 3 human clinical trials and commercial products for veterinary industry for clients both within Australia and internationally in the United States, Europe and Asia. In 2017 Luina Bio was the winner of the Queensland Government Export Awards for the Health and Biotechnology Industry and in 2018 was a winner in the Westpac Banking Top 200 Businesses of Tomorrow.Read More

Is Luina Bio a public company?
Luina Bio is private company therefore does not currently have an official ticker symbol
See more information about Luina Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.